SEC 13F Intelligence

Enavate Sciences GP, LLC / ZBIO

Enavate Sciences GP, LLC’s Zenas Biopharma Inc Position

Does Enavate Sciences GP, LLC own Zenas Biopharma Inc (ZBIO)? Yes — 3.92M shares worth $77M (+21.80% of its 13F portfolio) as of Q1 2026.

Position Value
$77M
Q1 2026
Shares
3.92M
% of Portfolio
+21.80%
Quarters Held
6
currently held

Position History ZBIO

Reported value by quarter
Q4 ’24: $31MQ4 ’24Q1 ’25: $30MQ1 ’25Q2 ’25: $36MQ2 ’25Q3 ’25: $84MQ3 ’25Q4 ’25: $142MQ4 ’25Q1 ’26: $77MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20263.92M$77M+21.80%
Q4 20253.92M$142M+28.08%
Q3 20253.76M$84M+25.49%
Q2 20253.76M$36M+20.65%
Q1 20253.76M$30M+22.39%
Q4 20243.76M$31M+22.12%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Enavate Sciences GP, LLC’s full portfolio or all institutional holders of ZBIO.